12-109581533-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000431.4(MVK):​c.510C>T​(p.Asp170Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.172 in 1,614,050 control chromosomes in the GnomAD database, including 24,479 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2294 hom., cov: 33)
Exomes 𝑓: 0.17 ( 22185 hom. )

Consequence

MVK
NM_000431.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13O:1

Conservation

PhyloP100: -4.43

Publications

39 publications found
Variant links:
Genes affected
MVK (HGNC:7530): (mevalonate kinase) This gene encodes the peroxisomal enzyme mevalonate kinase. Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis. Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
MVK Gene-Disease associations (from GenCC):
  • porokeratosis 3, disseminated superficial actinic type
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hyperimmunoglobulinemia D with periodic fever
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • mevalonic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • disseminated superficial actinic porokeratosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • porokeratosis of Mibelli
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 12-109581533-C-T is Benign according to our data. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-109581533-C-T is described in CliVar as Benign. Clinvar id is 129640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.43 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.187 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MVKNM_000431.4 linkc.510C>T p.Asp170Asp synonymous_variant Exon 5 of 11 ENST00000228510.8 NP_000422.1 Q03426B2RDU6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MVKENST00000228510.8 linkc.510C>T p.Asp170Asp synonymous_variant Exon 5 of 11 1 NM_000431.4 ENSP00000228510.3 Q03426

Frequencies

GnomAD3 genomes
AF:
0.170
AC:
25901
AN:
152076
Hom.:
2298
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.191
Gnomad AMI
AF:
0.216
Gnomad AMR
AF:
0.157
Gnomad ASJ
AF:
0.192
Gnomad EAS
AF:
0.140
Gnomad SAS
AF:
0.132
Gnomad FIN
AF:
0.0985
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.175
Gnomad OTH
AF:
0.173
GnomAD2 exomes
AF:
0.161
AC:
40401
AN:
251288
AF XY:
0.161
show subpopulations
Gnomad AFR exome
AF:
0.193
Gnomad AMR exome
AF:
0.145
Gnomad ASJ exome
AF:
0.184
Gnomad EAS exome
AF:
0.150
Gnomad FIN exome
AF:
0.104
Gnomad NFE exome
AF:
0.176
Gnomad OTH exome
AF:
0.166
GnomAD4 exome
AF:
0.172
AC:
252078
AN:
1461856
Hom.:
22185
Cov.:
35
AF XY:
0.171
AC XY:
124209
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.187
AC:
6264
AN:
33480
American (AMR)
AF:
0.145
AC:
6496
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.190
AC:
4973
AN:
26136
East Asian (EAS)
AF:
0.160
AC:
6344
AN:
39700
South Asian (SAS)
AF:
0.139
AC:
11948
AN:
86258
European-Finnish (FIN)
AF:
0.108
AC:
5745
AN:
53418
Middle Eastern (MID)
AF:
0.203
AC:
1170
AN:
5768
European-Non Finnish (NFE)
AF:
0.179
AC:
198736
AN:
1111980
Other (OTH)
AF:
0.172
AC:
10402
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
14070
28140
42209
56279
70349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7026
14052
21078
28104
35130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.170
AC:
25908
AN:
152194
Hom.:
2294
Cov.:
33
AF XY:
0.165
AC XY:
12246
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.191
AC:
7927
AN:
41528
American (AMR)
AF:
0.157
AC:
2401
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.192
AC:
664
AN:
3466
East Asian (EAS)
AF:
0.140
AC:
722
AN:
5160
South Asian (SAS)
AF:
0.130
AC:
629
AN:
4832
European-Finnish (FIN)
AF:
0.0985
AC:
1045
AN:
10608
Middle Eastern (MID)
AF:
0.177
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
0.175
AC:
11900
AN:
67990
Other (OTH)
AF:
0.176
AC:
371
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1120
2239
3359
4478
5598
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
272
544
816
1088
1360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.178
Hom.:
3943
Bravo
AF:
0.177
Asia WGS
AF:
0.151
AC:
524
AN:
3478
EpiCase
AF:
0.182
EpiControl
AF:
0.181

ClinVar

Significance: Benign
Submissions summary: Benign:13Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 21% of patients studied by a panel of primary immunodeficiencies. Number of patients: 20. Only high quality variants are reported. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:3Other:1
Nov 19, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Jan 16, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19888504, 15536479, 27190114, 11313769) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mevalonic aciduria Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Hyperimmunoglobulin D with periodic fever;C1867981:Porokeratosis 3, disseminated superficial actinic type;C1959626:Mevalonic aciduria Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Jan 20, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Hyperimmunoglobulin D with periodic fever Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.58
DANN
Benign
0.49
PhyloP100
-4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2287218; hg19: chr12-110019338; COSMIC: COSV57331947; COSMIC: COSV57331947; API